- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Tuberculosis Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Tuberculosis Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Tuberculosis Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Lupin
Epistem
Pfizer
Sandoz
Cepheid
AstraZeneca
BioMerieux
Otsuka Novel Products
EIKEN CHEMICAL
Archivel Farma
By Type:
First-line anti-TB drugs
Second-line anti-TB drugs
By End-User:
Active TB
Latent TB
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Tuberculosis Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Tuberculosis Drugs Market Size and Growth Rate of First-line anti-TB drugs from 2014 to 2026
1.3.2 Japan Tuberculosis Drugs Market Size and Growth Rate of Second-line anti-TB drugs from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Tuberculosis Drugs Market Size and Growth Rate of Active TB from 2014 to 2026
1.4.2 Japan Tuberculosis Drugs Market Size and Growth Rate of Latent TB from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Tuberculosis Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Tuberculosis Drugs by Major Types
3.4.1 Market Size and Growth Rate of First-line anti-TB drugs
3.4.2 Market Size and Growth Rate of Second-line anti-TB drugs
4 Segmentation of Tuberculosis Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Tuberculosis Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Tuberculosis Drugs in Active TB
4.4.2 Market Size and Growth Rate of Tuberculosis Drugs in Latent TB
5 Market Analysis by Regions
-
5.1 Japan Tuberculosis Drugs Production Analysis by Regions
-
5.2 Japan Tuberculosis Drugs Consumption Analysis by Regions
6 Hokkaido Tuberculosis Drugs Landscape Analysis
-
6.1 Hokkaido Tuberculosis Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Tuberculosis Drugs Landscape Analysis by Major End-Users
7 Tohoku Tuberculosis Drugs Landscape Analysis
-
7.1 Tohoku Tuberculosis Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Tuberculosis Drugs Landscape Analysis by Major End-Users
8 Kanto Tuberculosis Drugs Landscape Analysis
-
8.1 Kanto Tuberculosis Drugs Landscape Analysis by Major Types
-
8.2 Kanto Tuberculosis Drugs Landscape Analysis by Major End-Users
9 Chubu Tuberculosis Drugs Landscape Analysis
-
9.1 Chubu Tuberculosis Drugs Landscape Analysis by Major Types
-
9.2 Chubu Tuberculosis Drugs Landscape Analysis by Major End-Users
10 Kinki Tuberculosis Drugs Landscape Analysis
-
10.1 Kinki Tuberculosis Drugs Landscape Analysis by Major Types
-
10.2 Kinki Tuberculosis Drugs Landscape Analysis by Major End-Users
11 Chugoku Tuberculosis Drugs Landscape Analysis
-
11.1 Chugoku Tuberculosis Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Tuberculosis Drugs Landscape Analysis by Major End-Users
12 Shikoku Tuberculosis Drugs Landscape Analysis
-
12.1 Shikoku Tuberculosis Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Tuberculosis Drugs Landscape Analysis by Major End-Users
13 Kyushu Tuberculosis Drugs Landscape Analysis
-
13.1 Kyushu Tuberculosis Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Tuberculosis Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Sanofi
14.1.1 Sanofi Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Lupin
14.2.1 Lupin Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Epistem
14.3.1 Epistem Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Pfizer
14.4.1 Pfizer Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Sandoz
14.5.1 Sandoz Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Cepheid
14.6.1 Cepheid Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 AstraZeneca
14.7.1 AstraZeneca Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 BioMerieux
14.8.1 BioMerieux Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Otsuka Novel Products
14.9.1 Otsuka Novel Products Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 EIKEN CHEMICAL
14.10.1 EIKEN CHEMICAL Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Archivel Farma
14.11.1 Archivel Farma Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
The List of Tables and Figures (Totals 84 Figures and 125 Tables)
Figure Japan Tuberculosis Drugs Market Size and Growth Rate of First-line anti-TB drugs from 2014 to 2026
Figure Japan Tuberculosis Drugs Market Size and Growth Rate of Second-line anti-TB drugs from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Tuberculosis Drugs Market Size and Growth Rate of Active TB from 2014 to 2026
Figure Japan Tuberculosis Drugs Market Size and Growth Rate of Latent TB from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Tuberculosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Tuberculosis Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Tuberculosis Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Tuberculosis Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Tuberculosis Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of First-line anti-TB drugs
Figure Market Size and Growth Rate of Second-line anti-TB drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Tuberculosis Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Tuberculosis Drugs by Different End-Users from 2014 to 2026
Figure Japan Tuberculosis Drugs Market Size and Growth Rate of Active TB from 2014 to 2026
Figure Japan Tuberculosis Drugs Market Size and Growth Rate of Latent TB from 2014 to 2026
-
Table Japan Tuberculosis Drugs Production by Regions
-
Table Japan Tuberculosis Drugs Production Share by Regions
-
Figure Japan Tuberculosis Drugs Production Share by Regions in 2014
-
Figure Japan Tuberculosis Drugs Production Share by Regions in 2018
-
Figure Japan Tuberculosis Drugs Production Share by Regions in 2026
-
Table Japan Tuberculosis Drugs Consumption by Regions
-
Table Japan Tuberculosis Drugs Consumption Share by Regions
-
Figure Japan Tuberculosis Drugs Consumption Share by Regions in 2014
-
Figure Japan Tuberculosis Drugs Consumption Share by Regions in 2018
-
Figure Japan Tuberculosis Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Hokkaido Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Tuberculosis Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Tohoku Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Tohoku Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Tohoku Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Tuberculosis Drugs Consumption Share by End-Users in 2026
-
Table Kanto Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Kanto Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Kanto Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Kanto Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Tuberculosis Drugs Consumption Share by End-Users in 2026
-
Table Chubu Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Chubu Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Chubu Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Chubu Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Tuberculosis Drugs Consumption Share by End-Users in 2026
-
Table Kinki Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Kinki Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Kinki Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Kinki Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Tuberculosis Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Chugoku Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Chugoku Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Chugoku Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Tuberculosis Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Shikoku Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Shikoku Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Shikoku Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Tuberculosis Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Tuberculosis Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Tuberculosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Tuberculosis Drugs Consumption Share by Types in 2014
-
Figure Kyushu Tuberculosis Drugs Consumption Share by Types in 2018
-
Figure Kyushu Tuberculosis Drugs Consumption Share by Types in 2026
-
Table Kyushu Tuberculosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Tuberculosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Tuberculosis Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Tuberculosis Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Tuberculosis Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Sanofi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
Figure Sales and Growth Rate Analysis of Sanofi
Figure Revenue and Market Share Analysis of Sanofi
Table Product and Service Introduction of Sanofi
Table Company Profile and Development Status of Lupin
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin
Figure Sales and Growth Rate Analysis of Lupin
Figure Revenue and Market Share Analysis of Lupin
Table Product and Service Introduction of Lupin
Table Company Profile and Development Status of Epistem
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epistem
Figure Sales and Growth Rate Analysis of Epistem
Figure Revenue and Market Share Analysis of Epistem
Table Product and Service Introduction of Epistem
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Sandoz
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
Figure Sales and Growth Rate Analysis of Sandoz
Figure Revenue and Market Share Analysis of Sandoz
Table Product and Service Introduction of Sandoz
Table Company Profile and Development Status of Cepheid
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid
Figure Sales and Growth Rate Analysis of Cepheid
Figure Revenue and Market Share Analysis of Cepheid
Table Product and Service Introduction of Cepheid
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of BioMerieux
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux
Figure Sales and Growth Rate Analysis of BioMerieux
Figure Revenue and Market Share Analysis of BioMerieux
Table Product and Service Introduction of BioMerieux
Table Company Profile and Development Status of Otsuka Novel Products
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka Novel Products
Figure Sales and Growth Rate Analysis of Otsuka Novel Products
Figure Revenue and Market Share Analysis of Otsuka Novel Products
Table Product and Service Introduction of Otsuka Novel Products
Table Company Profile and Development Status of EIKEN CHEMICAL
Table Sales, Revenue, Sales Price and Gross Margin Analysis of EIKEN CHEMICAL
Figure Sales and Growth Rate Analysis of EIKEN CHEMICAL
Figure Revenue and Market Share Analysis of EIKEN CHEMICAL
Table Product and Service Introduction of EIKEN CHEMICAL
Table Company Profile and Development Status of Archivel Farma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Archivel Farma
Figure Sales and Growth Rate Analysis of Archivel Farma
Figure Revenue and Market Share Analysis of Archivel Farma
Table Product and Service Introduction of Archivel Farma
-